HLA-E*01:01 allele is associated with better response to anti-HCV therapy while homozygous status for HLA-E*01:03 allele increases the resistance to anti-HCV treatments in frequently transfused thalassemia patients

Autor: Hosseini, Ehteramolsadat, Sarraf Kazerooni, Ehsan, Azarkeivan, Azita, Sharifi, Zohreh, Shahabi, Majid, Ghasemzadeh, Mehran
Zdroj: In Human Immunology July 2022 83(7):556-563
Databáze: ScienceDirect